Exosomes in Ovarian Cancer: Promoters, Biomarkers, and Therapeutic Targets. [PDF]
Wang F, Dong H, Song Y, Zhang Y.
europepmc +1 more source
Decoding Drug Resistance in Pancreatic Cancer: A Subcellular Structure Perspective. [PDF]
Li X +11 more
europepmc +1 more source
Mechanisms Underlying Cancer Chemoresistance: A Starting Point to Identify New Anticancer Strategies. [PDF]
Domenicotti C, Marengo B.
europepmc +1 more source
MDM4 promotes chemoresistance in bladder cancer by attenuating P53-mediated EMT. [PDF]
Cai S +6 more
europepmc +1 more source
The allosteric IDH1 inhibitor ivosidenib overcomes chemoresistance in intrahepatic cholangiocarcinoma models expressing wild-type IDH1. [PDF]
Li X +9 more
europepmc +1 more source
Correction: Deficient or R273H and R248W mutations of p53 promote chemoresistance to 5-FU via TCF21/CD44 axis-mediated enhanced stemness in colorectal carcinoma. [PDF]
Gao X +8 more
europepmc +1 more source
NFIB Regulates Chemoresistance in Small Cell Lung Cancer by Suppressing Notch Signaling Activity. [PDF]
Qin W +5 more
europepmc +1 more source
Retraction: ANRIL promotes chemoresistance via disturbing expression of ABCC1 by regulating the expression of Let-7a in colorectal cancer. [PDF]
Liu P, Duan W, Zhang Z, Feng L.
europepmc +1 more source
Keratin 5 expression defines a niche-supported hierarchy in tubo-ovarian cancer. [PDF]
Tian Z, McLean K.
europepmc +1 more source
Mechanisms of chemoresistance in diffuse large B‑cell lymphoma and novel therapeutic strategies (Review). [PDF]
Wan M +5 more
europepmc +1 more source

